Epidermal growth factor receptor (EGFR) is a receptor with tyrosine kinase, and activating mutations in its tyrosine kinase domain promote several oncogene-driven malignancies in NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.